EcoDrugPlus

Proteasome 20s Subunit Beta 8a

Ensembl ID : ENSTRUG00000031292
Gene Symbol: PSMB8A
1 Cross references
212 Possible Orthologues:

Proteasome 20s Subunit Beta 8a

Ensembl ID : ENSTRUG00000033329
Gene Symbol: PSMB8A
1 Cross references
212 Possible Orthologues:

Proteasome 20s Subunit Beta 8a

Ensembl ID : ENSTRUG00000029914
Gene Symbol: PSMB8A
1 Cross references
212 Possible Orthologues:

Proteasome 20s Subunit Beta 8a

Ensembl ID : ENSTRUG00000029732
Gene Symbol: PSMB8A
1 Cross references
212 Possible Orthologues:

Proteasome 20s Subunit Beta 8a

Ensembl ID : ENSTRUG00000026348
Gene Symbol: PSMB8A
1 Cross references
212 Possible Orthologues:

Proteasome 26s Subunit Ubiquitin Receptor, Non-Atpase 4a

Ensembl ID : ENSTRUG00000024969
Gene Symbol: PSMD4A
1 Cross references
226 Possible Orthologues:

Proteasome 26s Subunit, Atpase 1

Ensembl ID : ENSTRUG00000003908
Gene Symbol: PSMC1
3 Cross references
281 Possible Orthologues:

Proteasome 26s Subunit, Atpase 3

Ensembl ID : ENSTRUG00000007383
Gene Symbol: PSMC3
4 Cross references
226 Possible Orthologues:

Proteasome 26s Subunit, Atpase 4

Ensembl ID : ENSTRUG00000006577
Gene Symbol: PSMC4
3 Cross references
197 Possible Orthologues:

Proteasome 26s Subunit, Atpase 6

Ensembl ID : ENSTRUG00000009258
Gene Symbol: PSMC6
1 Cross references
242 Possible Orthologues:

Proteasome 26s Subunit, Non-Atpase 1

Ensembl ID : ENSTRUG00000017396
Gene Symbol: PSMD1
3 Cross references
214 Possible Orthologues:

Proteasome 26s Subunit, Non-Atpase 11

Ensembl ID : ENSTRUG00000007262
Gene Symbol: PSMD11
4 Cross references
207 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).